ライフサイエンスコーパス: immunization program

1 used to monitor the impact of a US rotavirus immunization program.

2 roduce rotavirus vaccine into their national immunization program.

3 priority health programs like the Universal Immunization Program.

4 nly several countries with a funded male HPV immunization program.

5 ntroduce rotavirus vaccine into its national immunization program.

6 the shift from PCV7 to PCV13 in the national immunization program.

7 considered as a viable component of a global immunization program.

8 ost-effectiveness of which vaccine to use in immunization programs.

9 at the country level reinforces the national immunization programs.

10 ement and quality, and strengthening routine immunization programs.

11 pt rotavirus vaccination into their national immunization programs.

12 d the implications for triggered and routine immunization programs.

13 occal conjugate vaccine (PCV7) into national immunization programs.

14 pedes the establishment of effective routine immunization programs.

15 ization services as a strategy to strengthen immunization programs.

16 PV2 by ceasing use of tOPV in their national immunization programs.

17 se vaccines are introduced in routine infant immunization programs.

18 rts and may reflect the success of childhood immunization programs.

19 njugate vaccine (PCV7) developed in 34 state immunization programs.

20 o begin vaccine safety monitoring in routine immunization programs.

21 gent disease in countries with long-standing immunization programs.

22 red for incorporation into current childhood immunization programs.

23 cines makes the implementation of a national immunization program an important decision requiring eco

24 ause of low coverage achieved in the routine immunization program and in supplementary immunization a

25 Gs in the introduction of IPV in the routine immunization program and the lessons learned.

26 for almost all vaccines contained in global immunization programs and influence immune response for

27 er and into April, establishing school-based immunization programs and other alternative vaccination

28 itical tasks in the strengthening of routine immunization programs and the control of measles and rub

29 accine are useful to evaluate the success of immunization programs and to identify susceptible subgro

30 a significant achievement for public health immunization programs and underscores the importance of

31 cies, participating in the implementation of immunization programs, and establishing effective means

32 g gaps in the polio surveillance and routine immunization programs, and provided recommendations for

33 d personnel provide critical support for the immunization programs, and sudden discontinuation of the

34 is is required before further mass varicella immunization programs are set out.

35 ate Hib vaccine within the routine childhood immunization program at ages 6, 10, and 14 weeks beginni

36 reports of integration of MCH services with immunization programs at the service delivery level.

37 The Swine Influenza Immunization Program began in January 1976 with an outbr

38 In 2008, an HPV immunization program began with a bivalent vaccine (Cerv

39 hree particular lessons for other health and immunization programs can be drawn from the experience o

40 After immunization, programmed death -1 (PD-1)(high) T(FH) cel

41 However, the success of an immunization program depends on high rates of acceptance

42 urrently used to evaluate the impact of mass immunization programs for varicella and therefore extend

43 w rotavirus vaccines are being introduced in immunization programs, global and national estimates of

44 Before the switch, immunization programs globally had been using approximat

45 of circulating strains as part of a routine immunization program >5 years after its introduction in

46 virus (HPV) vaccine among girls in the Dutch immunization program has plateaued at around 60%.

47 Implementation of universal-at-birth HBV immunization programs has effectively reduced the occurr

48 al educational immunity through prepregnancy immunization programs has potential for improvement of i

49 The coverage of immunization programs has reached 60% in 85% of African

50 cently, however, new vigor and strategies in immunization programs have resulted in substantial impro

51 Introduction of PCV7 in the Dutch National Immunization Program in 2006 preluded substantial altera

52 tavirus vaccine into South Africa's national immunization program in August 2009.

53 V) at >/=14 weeks of age through the routine immunization program in countries currently not using IP

54 ost-benefit analysis of a national rotavirus immunization program in Egypt, from the perspective of t

55 evaluate the effectiveness of a hepatitis B immunization program in eliminating hepatitis B virus (H

56 The immunization program in Honduras has sufficient structur

57 V5) was introduced into the Israeli National Immunization Program in January 2011.

58 lent PCV was introduced to Israel's national immunization program in July 2009 and gradually replaced

59 was introduced in the routine public health immunization program in Lusaka, Zambia, in January 2012

60 MD vaccines are included in China's National Immunization Program in order to achieve high coverage r

61 rce for monitoring the impact of a rotavirus-immunization program in the United States.

62 ced into Alberta, Canada's routine childhood immunization programs in 2002 (7-valent [PCV7]) and 2010

63 Strengthened routine immunization programs in countries with suboptimal cover

64 tributed as seeds, tubers, or fruits, making immunization programs in developing countries cheaper an

65 immunogens could be particularly useful for immunization programs in developing countries, where des

66 njugate vaccines (PCVs) are used in national immunization programs in many developing countries.

67 vaccines can be incorporated into childhood immunization programs in the developing world.

68 eir employment would potentially disrupt the immunization programs in their countries and create a se

69 MR countries introduced IPV in their routine immunization program, including all of the countries at

70 ed RCV into their national routine childhood immunization programs increased by 57% from 83 countries

71 The routine immunization program information collected included ques

72 itis B vaccine and mass population screening immunization program initiated in 1984 on rates of HBV a

73 Immunization program managers from 48 states (96%) parti

74 A 2-phase mixed-methods study of state immunization program managers in the United States.

75 al telephone and paper-based survey of state immunization program managers that was conducted from Ja

76 om meetings and personal communications with immunization program managers.

77 wly approved vaccines into routine childhood immunization programs, monitoring their performance in r

78 measles surveillance system at the National Immunization Program (NIP).

79 Drawing from the ill-fated swine influenza immunization program of 1976, this article outlines 7 le

80 ccines have been implemented in the national immunization programs of 79 countries, including 36 low-

81 tivated polio vaccine (IPV) into the routine immunization programs of all countries using oral polio

82 dedicated to tasks related to strengthening immunization programs, other than polio eradication.

83 on of Hib vaccine into the routine childhood immunization program reduced Hib disease incidence among

84 rubella-containing vaccine in their national immunization programs, rubella and CRS continue to occur

85 tudies assess population immunity, verify an immunization program's performance and vaccine efficacy,

86 the type 2 component; and strengthen routine immunization programs-set an ambitious series of targets

87 HCP immunization programs should consider effects of host im

88 Future immunization programs should therefore target these tran

89 lowing introduction of RV1 into the national immunization program, significant declines in hospitaliz

90 e of intervention compatibility and focus on immunization program strength.

91 In 2000, the National Immunization Program surveyed states, the District of Co

92 A hepatitis B immunization program that includes prevention of perinat

93 communications from other aspects of oblast immunization programs, these and other outcome data sugg

94 repares for the full removal of all OPV from immunization programs, this need for lead time and consi

95 ntroduce rotavirus vaccine into its national immunization program to reduce the burden of rotavirus d

96 tOPV highlights the adaptability of national immunization programs to new procedures, and identifies

97 f adding a rotavirus vaccine to the Peruvian immunization program under 3 scenarios for the timing of

98 Integrated global immunization programs using live-attenuated oral (OPV) a

99 duction of rotavirus vaccine to the national immunization program was not found to be cost saving bas

100 ntil recently, waste management for national immunization programs was limited to sharps waste, empty

101 ends, and consider methods for evaluating an immunization program when a vaccine becomes available.

102 eports from countries' ministries of health, immunization programs, WHO, and NITAGs.

103 ction and sequelae is considerable, although immunization programs with broad coverage of the hyper v

104 te vaccine 13 (PCV13), are used in childhood immunization programs worldwide, but direct comparisons

105 A US rotavirus immunization program would be cost-effective from the pe

106 health care system, although the cost of the immunization program would not be fully offset by the re

107 A routine, universal rotavirus immunization program would prevent 1.08 million cases of